Cite
MLA Citation
Mario Terlizzi et al.. “Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.” Acta oncologica, vol. 60, 2021, pp. 1114–1121. http://access.bl.uk/ark:/81055/vdc_100140210723.0x000049